Estradiol 0.01% Vag Cream

DRUG3 trials

Sponsors

University of Alabama at Birmingham, TriHealth Inc., University of Arizona

Conditions

Anal IncontinenceDyspareuniaLichen Sclerosus of VulvaMenopauseObstetric; Injury Pelvic FloorPainful IntercoursePost-menopausePre-menopause

Phase 2

Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

Not yet recruitingNCT07260825

TriHealth Inc.Dyspareunia, Lichen Sclerosus of Vulva, Vulvodynia

Start: 2025-12-31End: 2026-08-31Target: 44Updated: 2025-12-03

Phase 4

Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery

TerminatedNCT05317364

University of Alabama at BirminghamAnal Incontinence, Obstetric; Injury Pelvic Floor, Sexual Dysfunction +1

Start: 2022-07-14End: 2026-02-13Updated: 2026-02-18

Unknown Phase

VEDA Study (DHEA vs Estradiol)

Not yet recruitingNCT07574216

University of ArizonaMenopause, Painful Intercourse, Post-menopause +3

Start: 2026-06-01End: 2031-12-31Target: 324Updated: 2026-06-17